KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) EBT Margin (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of EBT Margin data on record, last reported at 28.15% in Q4 2025.

  • For Q4 2025, EBT Margin rose 128.0% year-over-year to 28.15%; the TTM value through Dec 2025 reached 30.77%, up 229.0%, while the annual FY2025 figure was 30.77%, 229.0% up from the prior year.
  • EBT Margin reached 28.15% in Q4 2025 per IDXX's latest filing, down from 31.19% in the prior quarter.
  • Across five years, EBT Margin topped out at 32.66% in Q2 2025 and bottomed at 19.88% in Q2 2022.
  • Average EBT Margin over 5 years is 28.38%, with a median of 29.06% recorded in 2022.
  • Peak YoY movement for EBT Margin: surged 117820bps in 2021, then crashed -1059bps in 2022.
  • A 5-year view of EBT Margin shows it stood at 23.95% in 2021, then grew by 7bps to 25.73% in 2022, then grew by 3bps to 26.58% in 2023, then grew by 1bps to 26.87% in 2024, then grew by 5bps to 28.15% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 28.15% in Q4 2025, 31.19% in Q3 2025, and 32.66% in Q2 2025.